N/A
N=838
Prospective Study of Veteran Health in Previously Deployed Soldiers
Combat Disorders
Bottom Line
View on ClinicalTrials.gov: NCT00285246 ↗Enrolled (actual)
838
Serious AEs
0.0%
Results posted
Oct 2014
Primary outcome: Primary: Non-Specific Physical Symptoms — 5.2; 7.9; 7.7; 7.7 units on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- US Department of Veterans Affairs
- Primary completion
- Feb 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Non-Specific Physical Symptoms |
5.2; 7.9; 7.7; 7.7 | — |
| PRIMARY Physical Functional Status |
55.5; 53.7; 52.8; 51.5 | — |
| PRIMARY Mental Functional Status |
48.0; 45.7; 45.0; 44.9 | — |
| PRIMARY Health Care Utilization |
0.78; 0.68; 0.69; 1.11 | — |
Summary
Background: Previous deployments like that to the Persian Gulf in 1991 produced veterans with post-deployment symptom-based health problems with no medical explanation. This was termed Gulf War illness or medically unexplained illness (MUI). If previous wars are any indication, some soldiers currently deployed to hostile areas also will return home with unexplained symptom-based illnesses. However, when this study began there was virtually no pre-war, prospective data on risk and resilience factors associated with MUI. This study is attempting to fill that gap.
Objectives: Our goals are to: (a) determine pre- and immediate post-deployment factors predicting later MUI and poor functional status, (b) improve previous methodological problems (e.g., selection bias, recall bias and lack of baseline controls) in studies of MUI, and (c) relate pre-deployment risk factors (e.g., personality, stressor reactivity) and resilience factors (e.g., coping style, social support) to post-deployment functional status.
Eligibility Criteria
Inclusion Criteria
- Army Reserve and National Guard soldiers deploying to a hazardous deployment from Fort Dix, New Jersey (NJ) and Camp Shelby, Mississippi (MS)
Exclusion Criteria
- There are some drug exclusions for anything that substantially affects cardiovascular function.
Data sourced from ClinicalTrials.gov (NCT00285246). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.